Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Methods Leveraging the target trial emulation framework, we conducted a retrospective study using observational data to emulate a new user, active comparator trial examining the effects of initiating GLP-1RA (exposure group) versus SGLT2 inhibitors (control group), with random treatment assignment emulated by propensity score matching with 1:1 ratio
It may protect normal cells from oxidative injury, but elevated glutathione systems can also help tumour cells survive and resist treatment
ABSTRACT: ClinicalTrials.gov identifier: NCT04105504
It means you are paying a premium for the distribution model rather than the formulation itself
US$ 21.93
US$ 20.15
US$ 23.68
US$ 21.60
US$ 27.69
